(21) used the European Association of Urology guidelines on PCa, which are different from our classification standard, to classify low-intermediate- and high-risk patients and used 18F-PSMA-1007 PET/CT to identify non-metastatic high-risk PCa. Here, FOLH1 is linked to posterior cortical atrophy.